Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T24055 |
FAUC 213
FAUC213,FAUC-213 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
FAUC 213 是一种具有口服活性的‘、高度选择性的、可透过血脑屏障的多巴胺 D4受体完全拮抗剂,对 hD4.4的 Ki=2.2 nM。它对 D2和 D3受体的活性较低,对于 hD2、hD3的 Ki 分别为 3.4 μM、5.3 μM。它表现出非典型的抗精神病活性。 | |||
T14283 |
amyloid P-IN-1
|
Beta Amyloid | Neuroscience |
amyloid P-IN-1 可用于研究血清淀粉样蛋白 P 成分耗尽的疾病,例如阿尔茨海默病、淀粉样变性、骨关节炎和 2 型糖尿病。 | |||
T77575 |
P-gb-IN-1
|
P-gp | Membrane transporter/Ion channel; Neuroscience |
P-gb-IN-1 是一种有效的 P-糖蛋白 (P-gp) 抑制剂,通过抑制 P-gp 外流展现出逆转活性。P-gb-IN-1 通过与残基 Asn 721 和 Met 986 形成氢键相互作用从而显示出对 P-gp 的抑制作用。P-gb-IN-1 在 MCF-7/ADR 细胞中显示出低毒性。 | |||
T4031 |
S1p receptor agonist 1
S1p-receptor-agonist-1 |
S1P Receptor; LPL Receptor | GPCR/G Protein |
S1p receptor agonist 1 (S1p-receptor-agonist-1) 是有口服活性的S1P 受体激动剂,具有诱导 S1P1 内化的活性,EC50为9.83 nM。它有潜力用于关节炎和实验性自身免疫性脑炎)的相关研究。 | |||
T12341 |
P-gp inhibitor 1
|
Others; P-gp | Membrane transporter/Ion channel; Neuroscience; Others |
P-gp inhibitor 1 抑制逆转 P-糖蛋白介导的多药耐药性,EC50 为 57.9 nM(K562/A02 细胞)。 | |||
T3317 |
SZL P1-41
|
Apoptosis; Others; E1/E2/E3 Enzyme | Apoptosis; Others; Ubiquitination |
SZL P1-41 是 Skp2 抑制剂,可以阻止 Skp2-Skp1 复合物的组装。 它选择性地抑制 Skp2 SCF E3 连接酶活性,还在体内外抑制 Skp2 介导的 p27 和 Akt 泛素化。 它通过触发细胞衰老和抑制糖酵解来抑制 Y 细胞和 Y 干细胞的存活,有抗肿瘤作用。 | |||
T62536 |
S100P-IN-1
|
Others | Others |
S100P-IN-1 是一种高效的 S100P 抑制剂。S100P-IN-1 对胰腺癌 (pancreatic) 细胞具有抗转移作用。 | |||
T8703 |
yGsy2p-IN-1
|
Others | Others |
yGsy2p-IN-1 是酵母糖原合酶 2 抑制剂。它是竞争性人类糖原合酶 1 抑制剂(IC50:2.75 µM),对野生型 hGYS1 的Ki=为 1.31 µM。它是吡唑抑制剂,可用于糖原储存疾病的研究。 | |||
T72026 |
p53-MDM2-IN-1
|
Mdm2; p53 | Apoptosis |
p53-MDM2-IN-1 (Example 30) 是一种 p53-MDM2/X 蛋白相互作用的抑制剂,Ki 值为 23.35 µM。p53-MDM2-IN-1 能用于抗肿瘤研究。 | |||
T12347 |
p38-α MAPK-IN-1
|
p38 MAPK; Autophagy | Autophagy; MAPK |
p38-α MAPK-IN-1 是一种 MAPK14 (p38-α) 抑制剂,在 EFC 置换试验和 HTRF 试验中 IC50 分别为 2300 nM 和 5500 nM。 | |||
T9848 |
GSK2850163 (S enantiomer)
|
IRE1 | Cell Cycle/Checkpoint |
GSK2850163 (S enantiomer) 是 GSK2850163 的无活性对映体。GSK2850163 是一种新型的肌醇需求酶-1α (IRE1a) 抑制剂。 | |||
TP1819L |
Substance P 1-9 aceate
|
Neurotensin Receptor | GPCR/G Protein |
Substance P 1-9 aceate 是九肽,可减少豚鼠回肠和膀胱对 P 物质的失活。 | |||
T38648L |
Cecropin P1, porcine acetate
|
Endogenous Metabolite | Metabolism |
Cecropin P1, porcine acetate 是一种在 Hyalophora cecropia 和猪肠道中发现的抗菌肽。 | |||
T7675 |
Substance P (1-7) 2TFA(68060-49-1(free base))
|
Others | Others |
Substance P (1-7) 2TFA(68060-49-1(free base)) 是速激肽P(SP)蛋白水解降解后形成的主要生物活性代谢物,具有抗炎、抗伤害和抗痛觉过敏作用。 | |||
TP1549L |
NY-BR-1 p904 A2 acetate(347142-73-8 free base)
|
Others | Others |
NY-BR-1 p904 A2 acetate(347142-73-8 free base) 对这种 NY-BR-1 表位 (p904) 特异的 T 细胞克隆可以识别表达 NY-BR-1 的乳腺肿瘤细胞。 | |||
T62420 |
P2Y2R/GPR17 antagonist 1
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
P2Y2R/GPR17 antagonist 1 (Compound 14m) 是一种双重的 P2Y2R (IC50: 3.17 μM) 和 GPR17 (IC50: 1.67 μM) 拮抗剂。P2Y2R/GPR17 antagonist 1 在人肝微粒体中表现出极好的代谢稳定性。 | |||
T39459 |
THZ-P1-2
THZ-P1-2 |
||
THZ-P1-2 is a novel, specific inhibitor of PI5P4K that effectively targets PI5P4Kα. With an IC 50 of 190 nM, THZ-P1-2 selectively inhibits PI5P4Kα by forming covalent bonds with cysteine residues located on a disordered loop present in PI5P4Kα/β/γ. This mechanism not only disrupts autophagy but also elevates TFEB signaling. Moreover, THZ-P1-2 exhibits potent anticancer effects in leukemia cell lines, making it a promising candidate for therapeutic applications. | |||
T36806 |
TPC2-A1-P
TPC2-A1-P |
||
TPC2-A1-P is a powerful and membrane permeable agonist of two pore channel 2 (TPC2) with an EC50 of 10.5 μM. TPC2-A1-P plays its role by mimicking the physiological actions of PI(3,5)P2. TPC2-A1-P also shows higher potency to induce Na2+ mobilisation from TPC2 than TPC-A1-N . TPC2-A1-P can be used to probe different functions of TPC2 channels in intact cells[1][2][3]. Two-pore channels (TPC1-3) are ancient members of the voltage-gated ion channel superfamily. TPCs are expressed throughout the en... | |||
T38648 |
Cecropin P1, porcine
|
||
Cecropin P1, porcine is an antibacterial peptide originally identified in moths (Hyalophora cecropia) and later in pig intestine. | |||
T39798 |
S1P2 antagonist 1
|
||
S1P2 antagonist 1 is an orally bioavailable S1P2 antagonist against fibrotic diseases. | |||
T80372 |
P1
|
||
P1是一种具有抗革兰氏阳性菌与抗革兰氏阴性菌能力的广谱抗菌肽,有效针对B. anthracis、耐碳青霉烯类细菌A. baumannii和K. pneumoniae。 | |||
T12033 |
Micrococcin P1
微球菌素 P1 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Micrococcin P1 is a macrocyclic peptide antibiotic and is a potent hepatitis C virus (HCV) inhibitor(EC50 range of 0.1-0.5 μM) | |||
T78924 |
TPE-1p
|
||
TPE-1p为级联激活型AIEgen肽探针,具备在水溶液中自组装的能力,并对碱性磷酸酶(ALP)及ChT-L响应,展现出明亮的荧光。该探针适用于无创地评估ChT-L抑制剂在细胞内的抑制效能。 | |||
T40255 |
VCP/p97 inhibitor-1
VCP/p97 inhibitor-1 |
||
VCP/p97 inhibitor-1, a highly effective compound, inhibits VCP/p97 (also known as Cdc48, CDC-48, or Ter94) with an IC 50 of 54.7 nM. This inhibitor induces a disruption in protein homeostasis and interferes with the degradation process of misfolded polypeptides by the ubiquitin-proteasome system (UPS). | |||
T83393 |
293P-1
|
||
293P-1是一种特异性靶向肝细胞的组织特异性多肽,其序列为SNNNVRPIHIWP。 | |||
T76160 | Nuclease P1 | ||
Nuclease P1 (核酸酶 P1) 是一种单链特异性核酸内切酶,它将核酸水解为 5'-单核苷酸,并切割双链核酸的单链区域。Nuclease P1 是分子生物学领域著名的单链特异性核酸酶之一,广泛应用于制药和食品行业。 | |||
T61639 |
S1P1 agonist 4
|
||
S1P1 agonist 4 在效价(EC50< 0.05 mg/kg)和预测人类半衰期方面都有更好的表现 (t1/2 ~ 5 天)。 | |||
T61747 |
TTA-P1
|
||
TTA-P1 is a highly potent compound that effectively inhibits human T-type calcium channels, which are involved in various physiological processes such as neuronal burst firing, hormone secretion, and cell growth. With its unique state-independent properties, TTA-P1 holds promising potential for advancing research on absence epilepsy [1]. | |||
T40143 |
PROTAC CBP/P300 Degrader-1
PROTAC CBP/P300 Degrader-1 |
||
PROTAC CBP/P300 Degrader-1 is an effective compound that degrades CBP/P300 in a potent manner. It significantly reduces cell viability in various cancer cell lines. | |||
T62732 | S1P1 agonist 5 | ||
S1P1 agonist 5 是一种选择性的、口服具有活力的 S1P1 激动剂。S1P1 agonist 5 可以抑制淋巴细胞从淋巴组织排出到外周血。S1P1 agonist 5 具有潜力进行多发性硬化症 (MS) 的研究。 | |||
T79816 |
S1P1 agonist 6
|
LPL Receptor | GPCR/G Protein |
S1P1 agonist 6 (Compound I) 是一种可以通过阻断淋巴细胞迁移来减弱免疫反应的S1P1激动剂,常用于研究自身免疫性疾病的免疫抑制剂。 | |||
T81077 |
Substance P(1-4)
|
||
Substance P(1-4)为一有效的神经激肽受体(NK-R)拮抗剂,具有调节正常造血功能并抑制内源性红细胞集落(EEC)形成的能力。 | |||
T60491 | Elongation factor P-IN-1 | ||
Elongation factor P-IN-1 是 β-赖氨酸衍生化合物,是延伸因子 P (EFP) 的有效抑制剂,可影响大肠杆菌的增殖率。 | |||
T62316 | P-CAB agent 1 | ||
P-CAB agent 1 (compound B19) 是一种高效的钾离子竞争性酸阻滞剂,能够作用于 H+/K+-ATPase (IC50: 60.50 nM)。P-CAB agent 1 在大鼠中具表现出接受的口服吸收度。P-CAB agent 1 能够用于酸相关疾病 (ARDs) 的研究。 | |||
T7396 |
Substance P(1-7)
Substance P 1-7 |
Others; Neurokinin receptor | GPCR/G Protein; Neuroscience; Others |
Substance P(1-7) (Substance P 1-7) 是神经肽P 物质的片段,可对孤束核产生抑制和缓和作用,具有抗炎、抗伤害和抗痛觉过敏的作用。 | |||
T79817 |
S1P1 agonist 6 hemicalcium
|
LPL Receptor | GPCR/G Protein |
S1P1 agonist 6 hemicalcium (Compound I) 为一S1P1激动剂,其通过抑制淋巴细胞迁移而降低免疫反应,适用于自身免疫性疾病研究中的免疫抑制剂。 | |||
TMIH-0290 |
Ketorolac-d5-P1
|
||
Ketorolac-d5-P1 是 Ketorolac 的氘代化合物。Ketorolac 的 CAS 号为 74103-06-3。Ketorolac 是非甾体抗炎剂,是非选择性的COX抑制剂,对 COX-1 和 COX-2 的IC50值分别为 20 和 120 nM。 | |||
T81441 |
PLK1/p38γ-IN-1
|
p38 MAPK | MAPK |
PLK1/p38γ-IN-1(化合物14)为PLK1与p38γ多靶点抑制剂,体外有效抑制人肝细胞癌与肝母细胞瘤细胞增殖。 | |||
T124198 |
Sorbic acid, 1-p-tolylhydrazide
|
||
Sorbic acid, 1-p-tolylhydrazide 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T124198。 | |||
T37030 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt)
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) |
||
The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(4)-P1 (1,2-dioctanoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) featuring C8:0 fatty acids at the sn-1 and sn-2 positions. The compound contains the same inositol and diacylglycerol (DAG) stereochemistry as the natural compound. PtdIns-(4)-P1 can be phosphorylated to di- ... | |||
T63767 | P300 bromodomain-IN-1 | ||
P300 bromodomain-IN-1 是 p300 (EP300) bromodomain 的有效抑制剂 (IC50: 49 nM)。P300 bromodomain-IN-1 能够阻碍 c-Myc 的表达,并诱导 OPM-2 细胞的细胞周期阻滞在 G1/G0 期及诱导其凋亡 (apoptosis)。 | |||
T78606 | P2X3-IN-1 | P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
P2X3-IN-1(示例7)为P2X3受体抑制剂,适用于神经源性疾病的研究。 | |||
T63267 |
P-gp/BCRP-IN-1
|
||
P-gp/BCRP-IN-1 (compound 19) 是一种潜在的、相对安全的、口服有效的外排转运蛋白(P-gp 和 BCRP) 抑制剂。P-gp/BCRP-IN-1 通过抑制 P-gp 和BCRP 的外排功能产生耐药性逆转,P-gp/BCRP-IN-1可克服紫杉醇的耐药性,提高紫杉醇的口服生物利用度。 | |||
T75399 | GlcNAc 1-P uridyltransferase (CjGlmU) | ||
GlcNAc 1-P uridyltransferase (CjGlmU) 为一种糖核苷酸转移酶,以UTP和GlcNAc-1-P为天然底物,负责合成UDP-GlcNAc。此酶展现出潜在的抗菌活性分子研究价值。 | |||
T78352 |
N-acetylglucosamine-1-P uridyltransferase (AGX1)
GlcNAc1pUT |
||
N-acetylglucosamine-1-P uridyltransferase (AGX1) (GlcNAc1pUT) 是具有双功能乙酰转移酶/尿苷转移酶活性的原核生物专有酶。该酶能结合GlcNAc-1-P与UTP,催化合成UDP-GlcNAc的尿苷酰转移反应。 | |||
T36938 |
PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt)
PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) |
||
The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(3)-P1 (1,2-dioctanoyl) is a synthetic analog of natural PtdIns featuring C8:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and DAG stereochemistry as the natural compound. PtdIns-(3)-P1 can be phosphorylated to di- (PtdIns-P2; PIP2) and triphosphates (Ptd... | |||
T72877 | p53-HDM2-IN-1 | ||
p53-HDM2-IN-1 是一种有效的 p53-HDM2蛋白-蛋白相互作用抑制剂,IC50值为 0.103 μM。p53-HDM2-IN-1 可用于癌症研究。 | |||
T75963 |
Substance P(1-7) TFA
|
||
Substance P(1-7) TFA,为神经肽P物质(SP)的一个片段,能对孤束核产生抑制和缓和效果。 | |||
T67054 |
1-(P-Toluenesulfonyl)imidazole
|
||
1-(P-Toluenesulfonyl)imidazole 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T67054,CAS号为 2232-08-8。 | |||
T64079 | Mutant p53 modulator-1 | ||
Mutant p53 modulator-1 是一种突变型 p53 调节剂。Mutant p53 modulator-1 能够阻碍含有 p53 突变的癌症的进展。 |